Marin,
+17 Starkstein, Petracca, Chemerinski,
+18 and Andersson, Krogstad, and Finset
+13 have suggested that the common overriding characteristic of these disorders could be encapsulated into a concept of apathy. Marin
+17,+19 has operationalized the concept of apathy in terms of ability, interest, initiation of activity, motivation, awareness, and effective functioning into an 18-item rating scale, the Apathy Evaluation Scale (AES). Although the AES was essentially designed to diagnose and measure the severity of apathy,
+17 it has also been employed for case identification in neurological populations.
+6,+13,+20 Its psychometric properties have been found to be effective in some studies
+14,+15,+21—+23 but not in others.
+24 Interestingly, the concept of neurologically based apathy has been difficult to distinguish from depression in some patients.
+25 Both seem to occur in significant proportions in the brain injury population.
+26 While some studies have noted that apathy and depression seem to refer to separate entities, these studies were not executed in cross-cultural populations. Further, few studies have examined the validity of the AES in cross-cultural populations. It is not clear that a measure of apathy developed in a Western culture might have such a broad applicability as to appropriately apply in Oman. The AES may rely on behaviors and attitudes essentially limited to European and North American cultural groups. Further, it is not clear that the problem of passivity or apathy that is so prevalent among those with brain injury in the West might also be as prevalent in the culture of Oman. If we are to apply the AES to those who suffer brain injury outside of the European cultural catchment, we must first explore whether such a use is appropriate. As an initial step, studies are needed to clarify whether a disturbance of motivation is similarly prevalent or disruptive in cross-cultural populations. Second, it is important to determine whether there is a distinction between depression and apathy in the Omani population. For example, Pang et al.
+27 showed that, in contrast to their American counterparts, patients with Alzheimer’s disease in a Chinese environment exhibit apathy and depression that are unlikely to be viewed with contempt or as a social burden by their society. In the Arab world, disturbances of mood frequently manifest in a somatic metaphor
+28 that contrasts with the "cognitive metaphor" often discussed among populations in the industrialized world. To explore these issues, therefore, it is important to first measure the incidence of apathy. We, therefore, sought to use the AES to measure the incidence of apathy in an Omani brain-injury population. Since the AES elicits symptoms of both apathy and depression, we also examined whether AES could discriminate between depression and apathy among patients in our sample.